Catastrophic drug coverage: utilization insights from the Ontario Trillium Drug Program
Tadrous M, Greaves S, Martins D, Mamdani MM, Juurlink DN, Gomes T. CMAJ Open. 2018; 6(1):E132-8. Epub 2018 Mar 26.
Publications
Opioid prescribing and adverse events in opioid-naive patients treated by emergency physicians versus family physicians: a population-based cohort study
Borgundvaag B, McLeod S, Khuu W, Varner C, Tadrous M, Gomes T. CMAJ Open. 2018; 6(1):E110-7. Epub 2018 Mar 5.
Publicly funded overactive bladder drug treatment patterns in Ontario over 15 years: an ecologic study
Tadrous M, Elterman D, Khuu W, Mamdani MM, Juurlink DN, Gomes T. Can Urol Assoc J. 2018; 12(3):E142-5. Epub 2017 Dec 22.
Changes in the dispensing of opioid medications in Canada following the introduction of a tamper-deterrent formulation of long-acting oxycodone: a time series analysis
Gomes T, Mastorakos A, Paterson JM, Sketris I, Caetano P, Greaves S, Henry D; the Canadian Network for Observational Drug Effect Studies Investigators. CMAJ Open. 2017; 5(4):E800-7. Epub 2017 Nov 22.
Prior authorization and Canadian public utilization of direct-acting oral anticoagulants
Gao L, Tadrous M, Knowles S, Mamdani M, Paterson JM, Juurlink D, Gomes T. Healthc Policy. 2017; 13(2):68-78.
Effectiveness of oral bisphosphonates in reducing fracture risk among oral glucocorticoid users: three matched cohort analyses
Amiche MA, Levesque LE, Gomes T, Adachi JD, Cadarette SM. J Bone Miner Res. 2018; 33(3):419-29. Epub 2017 Oct 25.
Real-world healthcare utilization and effectiveness of omalizumab for the treatment of severe asthma
Tadrous M, Khuu W, Lebovic G, Stanbrook MB, Martins D, Paterson JM, Mamdani MM, Juurlink DN, Gomes T. Ann Allergy Asthma Immunol. 2018; 120(1):59-65.e2. Epub 2017 Oct 3.
Impact of a graduated approach on opioid initiation and loss of earnings following workplace injury: a time series analysis
Gomes T, Duesburry J, Theriault ME, Bain D, Singh S, Martins D, Juurlink D. J Occup Environ Med. 2017; 59(12):1197-201. Epub 2017 Oct 3.
Gabapentin, opioids and the risk of opioid-related death: a population-based nested case-control study
Gomes T, Juurlink DN, Antoniou T, Mamdani MM, Paterson JM, van den Brink W. PLoS Med. 2017; 14(10):e1002396. Epub 2017 Oct 3.
Prevalence and characteristics of opioid-related deaths involving alcohol in Ontario, Canada
Gomes T, Juurlink DN, Mamdani MM, Paterson JM, van den Brink W. Drug Alcohol Depend. 2017; 179:416-23. Epub 2017 Aug 31.